TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
批准号:
6342005
负责人:
SHU-WING NG
金额:
$11.87万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-15 至 2002-12-31
关键词:
CHO cells DNA gyrase antineoplastics binding proteins complementary DNA drug resistance gel mobility shift assay gene expression genetic promoter element genetic regulation genetic transcription isozymes messenger RNA neoplasm /cancer chemotherapy nuclear runoff assay tissue /cell culture transfection
中文摘要
II型DNA拓扑异构酶(topII)是一种必需的酶,也是
细胞内靶向的临床最有效的
间谍。 细胞内的top II是一个重要的
细胞对top II靶向敏感性的决定因素
药物和减少top II表达是最常见的观察到的顶部
II介导的耐药性。 在两种最高II亚型中,170 kD
形式(top II alpha)是介导top II功能的主要形式
对II类靶向药物高度敏感。 转染和
通过负反馈机制过度表达Top II α基因,
对于严格调节细胞顶II α水平是重要的
也可能有助于降低药物中的top II α表达,
阻力 此外,一个顺式元件及其各自的结合
在中国仓鼠顶部II α启动子中鉴定了活性,
它与c-erbB 2中的一种新的抑制元件相似,
启动子 top II α和c-erbB 2的扩增和过表达
基因与乳腺癌的不良预后有关。 因此,我们认为,
对top II alpha调节机制的研究
显著的生物学和临床相关性。
在这个提议中,控制自动调节的分子机制
在过表达CHO的EMT 6细胞中内源性top II alpha表达的
top II α和两种耐药细胞中top II α表达降低,
将对中国仓鼠细胞系进行研究和比较。 的
研究结果将被用于研究如何调节顶II α,
在耐药细胞系中的表达和药物敏感性
将对细胞进行分析。 基于CHO和人之间的高度同源性,
II α启动子和保守的调控元件,
因素,这项研究的结果是相关的研究顶端II
在人类癌症中的表达,并制定克服
II类介导的癌症化疗耐药性。 阐明
调节tip II α表达的机制也很重要,
研究top II在不同细胞功能中的作用。
英文摘要
Type II DNA topoisomerase (topII) is an essential enzyme and is also the
intracellular target for the number of clinically most effective
antineoplastic agents. The intracellular level of top II is an import
determining factor for the cellular sensitivity to top II-targeting
drugs and reduced top II expression is the most commonly observed top
II-mediated drug resistance. Of the two top II isoforms, the 170 kD
form (top IIalpha) is the predominant form to mediate top II functions
and is highly sensitive to top II-targeting agents. Transfection and
overexpression of top IIalpha gene by negative feedback mechanism, which
is important for a strict regulation of the cellular top IIalpha level
and may also contribute to reduced top IIalpha expression in drug
resistance. In addition, one cis-element and its respective binding
activity was identified in the Chinese hamster top IIalpha promoter and
it bears resemblance to a novel inhibitory element in the c-erbB2
promoter. Amplification and overexpression of top IIalpha and c-erbB2
genes have been associated with poor prognosis in breast cancer. Hence,
the study of mechanisms by which top IIalpha is regulated has
significant biological and clinical relevance.
In this proposal, the molecular mechanisms governing the autoregulation
of endogenous top IIalpha expression in EMT6 cells that overexpress CHO
top IIalpha and the reduced top IIalpha expression in two drug resistant
Chinese hamster cell lines will be investigated and compared. The
results will then be used in the study of modulating the top IIalpha
expression in the resistant cell lines and the drug sensitivity of the
cells will be assayed. Based on the high homology between CHO and human
to IIalpha promoters and the conserved regulatory elements and binding
factors, the results of this study are relevant for the study of top II
expression in human cancer and for developing strategies in overcoming
top II-mediated drug resistance in cancer chemotherapy. Elucidating the
mechanisms of regulating tip Iialpha expression is also important in
studying the roles of top II in different cell functions.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cloning and characterization of the 5'-flanking sequence for the human DNA topoisomerase II beta gene.
人类 DNA 拓扑异构酶 II β 基因 5 侧翼序列的克隆和表征。
DOI:
10.1016/s0378-1119(97)00500-3
发表时间:
1997
期刊:
Gene
影响因子:
3.5
作者:
[Ng,SW, Liu,Y, Schnipper,LE]
通讯作者:
Schnipper,LE
DOI:
10.1016/j.neulet.2012.01.062
发表时间:
2012-03-14
期刊:
Neuroscience letters
影响因子:
2.5
作者:
[Tsukiyama T, Yamaguchi TP]
通讯作者:
Yamaguchi TP
Analysis of p73 in human borderline and invasive ovarian tumor.
人类交界性和侵袭性卵巢肿瘤中 p73 的分析。
DOI:
10.1038/sj.onc.1203512
发表时间:
2000
期刊:
Oncogene
影响因子:
8
作者:
[Ng,SW, Yiu,GK, Liu,Y, Huang,LW, Palnati,M, Jun,SH, Berkowitz,RS, Mok,SC]
通讯作者:
Mok,SC
DOI:
--
发表时间:
2002-08
期刊:
Molecular cancer therapeutics
影响因子:
5.7
作者:
[Kuan-Chun Huang;P. Rao;C. Lau;E. Heard;S. Ng;Carolyn Brown;S. Mok;R. Berkowitz;S. Ng]
通讯作者:
Kuan-Chun Huang;P. Rao;C. Lau;E. Heard;S. Ng;Carolyn Brown;S. Mok;R. Berkowitz;S. Ng
Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
耐药细胞系中拓扑异构酶 IIα 表达下调所涉及的启动子元件的表征。
DOI:
10.1016/j.gene.2004.07.033
发表时间:
2004
期刊:
Gene
影响因子:
3.5
作者:
[Saxena,Deepa, Yiu,GaryK, Ni,Xiaoyan, Huang,Kuan-Chun, Mantovani,Roberto, Jacquemin-Sablon,AlainG, Ng,Shu-Wing]
通讯作者:
Ng,Shu-Wing
Targeting lipid metabolic and signaling enzyme in ovarian cancer
-
批准号:7873528
-
项目类别:
-
资助金额:$21.79万
-
财政年份:2010
-
负责人:SHU-WING NG
-
依托单位:
Targeting lipid metabolic and signaling enzyme in ovarian cancer
-
批准号:8049249
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2010
-
负责人:SHU-WING NG
-
依托单位:
XIST RNA and Ovarian Cancer
-
批准号:6874973
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2004
-
负责人:SHU-WING NG
-
依托单位:
XIST RNA and Ovarian Cancer
-
批准号:6712604
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2004
-
负责人:SHU-WING NG
-
依托单位:
Biomarkers for Ovarian Cancer
-
批准号:6622897
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2002
-
负责人:SHU-WING NG
-
依托单位:
Biomarkers for Ovarian Cancer
-
批准号:6458955
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2002
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6386613
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6130864
-
项目类别:
-
资助金额:$28.15万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6520086
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE III AND GENOMIC INSTABILITY
-
批准号:6636344
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2009539
-
项目类别:
-
资助金额:$5.57万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2633924
-
项目类别:
-
资助金额:$6.21万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2739730
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:6137566
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
TOPOISOMERASE II EXPRESSION IN DRUG RESISTANCE
-
批准号:2856413
-
项目类别:
-
资助金额:$11.87万
-
财政年份:1997
-
负责人:SHU-WING NG
-
依托单位:
海外基金